Janus Kinase Inhibitors Improve Disease Activity and Patient-Reported Outcomes in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis of 24,135 Patients

Pain, fatigue, and physical activity are major determinants of life quality in rheumatoid arthritis (RA). Janus kinase (JAK) inhibitors have emerged as effective medications in RA and have been reported to exert direct analgesic effect in addition to reducing joint inflammation. This analysis aims t...

Descripción completa

Detalles Bibliográficos
Autores principales: Tóth, Lilla, Juhász, Márk F., Szabó, László, Abada, Alan, Kiss, Fruzsina, Hegyi, Péter, Farkas, Nelli, Nagy, György, Helyes, Zsuzsanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836107/
https://www.ncbi.nlm.nih.gov/pubmed/35163173
http://dx.doi.org/10.3390/ijms23031246

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836107/
https://www.ncbi.nlm.nih.gov/pubmed/35163173
http://dx.doi.org/10.3390/ijms23031246

Ejemplares similares